Robert Janssen - 10 Feb 2025 Form 4 Insider Report for DYNAVAX TECHNOLOGIES CORP (DVAX)

Role
SVP and CMO
Signature
/s/ Robert Janssen
Issuer symbol
DVAX
Transactions as of
10 Feb 2025
Net transactions value
-$23,509
Form type
4
Filing time
12 Feb 2025, 16:57:13 UTC
Previous filing
20 Feb 2024
Next filing
18 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DVAX Common Stock Options Exercise +4,333 +7.4% 63,017 10 Feb 2025 Direct F1
transaction DVAX Common Stock Tax liability $23,509 -1,781 -2.8% $13.20 61,236 10 Feb 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DVAX Restricted Stock Unit Options Exercise -4,333 -100% 0 10 Feb 2025 Common Stock 4,333 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022.
F2 Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units.